714 related articles for article (PubMed ID: 19345990)
1. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
2. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
Tseng CL; Wang TW; Dong GC; Yueh-Hsiu Wu S; Young TH; Shieh MJ; Lou PJ; Lin FH
Biomaterials; 2007 Sep; 28(27):3996-4005. PubMed ID: 17570484
[TBL] [Abstract][Full Text] [Related]
3. Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer.
Tseng CL; Wu SY; Wang WH; Peng CL; Lin FH; Lin CC; Young TH; Shieh MJ
Biomaterials; 2008 Jul; 29(20):3014-22. PubMed ID: 18436301
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
7. Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
Ye H; Jin L; Hu R; Yi Z; Li J; Wu Y; Xi X; Wu Z
Biomaterials; 2006 Dec; 27(35):5958-65. PubMed ID: 16949149
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.
Ajima K; Murakami T; Mizoguchi Y; Tsuchida K; Ichihashi T; Iijima S; Yudasaka M
ACS Nano; 2008 Oct; 2(10):2057-64. PubMed ID: 19206452
[TBL] [Abstract][Full Text] [Related]
9. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
[TBL] [Abstract][Full Text] [Related]
11. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system.
Ding D; Zhu Z; Li R; Li X; Wu W; Jiang X; Liu B
ACS Nano; 2011 Apr; 5(4):2520-34. PubMed ID: 21428432
[TBL] [Abstract][Full Text] [Related]
12. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
13. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture.
Wang Y; Nakamura K; Liu X; Kitamura N; Kubo A; Hnatowich DJ
Bioconjug Chem; 2007; 18(4):1338-43. PubMed ID: 17605463
[TBL] [Abstract][Full Text] [Related]
14. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
Hirai M; Minematsu H; Hiramatsu Y; Kitagawa H; Otani T; Iwashita S; Kudoh T; Chen L; Li Y; Okada M; Salomon DS; Igarashi K; Chikuma M; Seno M
Int J Pharm; 2010 May; 391(1-2):274-83. PubMed ID: 20211714
[TBL] [Abstract][Full Text] [Related]
15. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
[TBL] [Abstract][Full Text] [Related]
16. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
Feng Z; Lai Y; Ye H; Huang J; Xi XG; Wu Z
Cancer Sci; 2010 Nov; 101(11):2476-82. PubMed ID: 20813014
[TBL] [Abstract][Full Text] [Related]
17. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin.
Mo Y; Lim LY
J Control Release; 2005 Nov; 108(2-3):244-62. PubMed ID: 16213056
[TBL] [Abstract][Full Text] [Related]
19. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
[TBL] [Abstract][Full Text] [Related]
20. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]